Search results for “Macrovascular disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 66 patents, we discovered top 18 key players by total patent application. Australian Biomedical Co. Pty Ltd., Ajinomoto Co., Inc., Cerenis Therapeutics, Inc. are dominant in this area. They take 34.85% of the total patent filing.
Australia
Patent: 10
Tokyo-to, Japan
Patent: 7
Michigan, United States
Patent: 6
France
Patent: 4
United States
Patent: 4
Hovedstaden, Denmark
Patent: 3
Victoria, Australia
Patent: 3
District of Columbia, United States
Patent: 3
United Kingdom
Patent: 3
Colorado, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents applied in the last 5 years. We discover 2 most active companies in this area.
undefined undefined
Patent: 1
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents in last 5 years, we discover 2 new entrants.
undefined undefined
Patent: 1
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 3 universities and scientific research institutions by total patent application.
New York, United States
Patent: 12
Shanghai Shi, China
Patent: 1
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: